Guardant Health and Ohio State University to Study Colon Cancer Screening Adherence
Guardant Health and Ohio State University will evaluate patient compliance with a blood-based test for colorectal cancer (CRC) screening.
Read MorePosted by Andy Lundin | Apr 6, 2023 | Colorectal |
Guardant Health and Ohio State University will evaluate patient compliance with a blood-based test for colorectal cancer (CRC) screening.
Read MorePosted by Andy Lundin | Apr 5, 2023 | Colorectal |
Guardant Health submitted the final module of its premarket approval application for a colon cancer screening blood test to the FDA.
Read MorePosted by Andy Lundin | Apr 5, 2023 | Lab Management |
TestDirectly, a direct-to-consumer (DTC) web portal, now supports provider insurance discovery and insurance eligibility checks.
Read MorePosted by Andy Lundin | Mar 31, 2023 | Unknown Origin & Other Cancer Types |
IVDR-certification has been granted for eight CytoCell FISH probes for patient management in haematological cancers and prenatal conditions.
Read MorePosted by Chris Wolski | Mar 22, 2023 | Calibrators, Quality Control Programs |
Regulations and guidelines sometimes make it difficult to perform linearity testing and calibration verification in a useful way.
Read More